Developed Genteract’s novel analysis methodologies. Published seven peer-reviewed papers, identified two new genetic disorders, and repurposed an existing cancer therapy for treatment through a new mechanism.
Former President Nio Games,, Former CTO, iSyndicate and others, Former Bio-researcher
MS in Quantitative Biomedical Science from Dartmouth. Applied data science methods to accurately establish biologically and analytically correct predictions of anti-drug antibodies induced by biologic treatments for HIV.
Former CEO, Ulthera
Distinguished Chair in Geriatrics
UT Southwestern Cell Biology,
Telomeres, Aging and Cancer
University of Ghent, Computational Biology, Genomics
Former lead developer at Scitivate, DealRoom, Fundology
MS in Computer Science
BS in Computer Science